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The painful palmoplantar keratoderma (PPK) arising in individuals with pachyonychia 
congenita (PC) exhibit a significant upregulation of danger-associated molecular patterns and 
skin barrier regulators. Mice null for keratin 16 (Krt16), one of the genes mutated in PC, 
faithfully reproduce the morphological and molecular features of PC-associated PPK. We 
show here that onset of PPK is preceded by oxidative stress in male Krt16-/- mouse footpad 
skin, correlating with an inability of keratinocytes to sustain Nrf2-dependent expression of 
enzymes involved in the synthesis of the cellular antioxidant glutathione (GSH). Hypoactivity 
of Nrf2 coincides with impaired PKCδ activity and reduced levels of RACK1 protein in Krt16-
/- footpad skin. Topical application of the small-molecule Nrf2 activator sulforaphane (SF) in 
male Krt16-/- mice prevents the development of PPK alongside a normalization of redox 
balance via the stimulation of GSH reductase and regeneration of GSH from existing cellular 
pools. Relative to males, female Krt16-/- mice exhibit faulty responsiveness to SF treatment. 
Preliminary data suggests that dual treatment of footpad skin with SF and selective estrogen 
receptor β agonist diarylpropionitrile (DPN) prevents the development of PPK lesions in 
female Krt16-/- mice. These findings point to oxidative stress and hypoactive Nrf2 as 
contributors to the pathogenesis of PC-related PPK and identify K16 as a regulator of the 
RACK1-PKCδ-NRF2 axis in skin keratinocytes. This pathway appears to be more complex 
in female Krt16-/- mice due to fundamental sex-based differences and, specifically, to a 
significant contribution of estrogen receptor signaling to modulation of Nrf2 function in skin 
keratinocytes. Our findings suggest a potential avenue to treat PC-associated PPK and may 
extend to similar keratin-based disorders.  
THESIS COMMITTEE 






I would first like to thank Dr. Pierre Coulombe for allowing me the opportunity to 
work in his laboratory and be part of not only a wonderful research team, but also such an 
amazing project. I have grown tremendously as an individual and a scientist, and I am 
extremely grateful for the training and intellectual stimulation over the past two years.  
To Dr. Michael Caterina, for agreeing to be my secondary reader and offering great 
insight and suggestions for this thesis. It has also been a wonderful experience learning about 
the fascinating work being done in your laboratory during our joint lab meetings. 
To Dr. Michelle Kerns, for her mentorship and teaching. Your guidance has taught 
me how to think scientifically and your ideas are inspiring. I am constantly pushed to perform 
better and rise to the occasion, and I am thankful to have worked on your team. 
To Drs. Beau Su and Ryan Hobbs, for their generosity and scientific expertise in 
helping me navigate the laboratory, whether I encountered equipment issues or had questions 
regarding protocols and troubleshooting. 
To the entire Coulombe laboratory, for creating a collegial and collaborative 
environment in which to work. Thank you for your critiques and suggestions during laboratory 
meetings and being supportive of my work and career goals. 
To the BMB faculty and staff, thank you for creating a home away from home during 
my time at JHSPH. To Dr. Janice Evans, for advising me during my time in BMB on both 
academic and professional development. To Shannon Gaston, for guiding me through the 
logistics of my program and reminding me of deadlines when they slipped my mind. 
To my family and friends, I cannot thank you enough for keeping me grounded and 
supporting my professional pursuits. For helping me through difficult times, being there to 




TABLE OF CONTENTS 
 
Abstract                   ii 
Acknowledgements                 iii 
List of Figures                 vi 
List of Tables                 vii 
List of Abbreviations               viii 
Introduction                    1 
Keratins                   1         
Pachyonychia congenita                 3   
Keratin 16 null mice: faithful model of pachyonychia congenita-associated palmoplantar           4 
keratoderma 
Redox balance of the skin                 4 
Nrf2 signaling pathway as a regulator of redox balance             6 
Estrogen signaling as a regulator of redox balance              7 
Results                  10 
Impaired glutathione synthesis in pre-lesional male Krt16-/- front paw tissue          10 
Lowering GSH levels causes PPK-like alterations in WT mouse skin           10 
The transcription factor Nrf2 is expressed, but is hypoactive in pre-lesional           12 
male Krt16-/- front paw skin 
Elucidating the link between Krt16 and Nrf2 activation            13 
Small molecule-based activation of Nrf2 rescues PPK in male Krt16-/- mice          15 
Topical treatment of Krt16-/- paws with SF exhibits sex-specific effects           17 
Manipulation of ER signaling impacts responsiveness to SF treatment in           18 




Discussion                  20 
Materials and Methods                22 
Appendix I                  26 
References                  37 





LIST OF FIGURES 
 
Figure 1. Keratin gene family tree.                 1 
Figure 2. Specificity of keratin expression in human epidermis.             2 
Figure 3. Plantar skin of PC patient.                 3 
Figure 4. Schematic representation of GSH metabolism.              5 
Figure 5. Schematic representation of KEAP1-NRF2 signaling pathway.            6 
Figure 6. Decrease in GSH synthesis in male Krt16-/- pre-lesional paw skin enzymes.           10 
Figure 7. Systemic BSO treatment results in increased oxidative burden and           11 
   epidermal changes in male murine paw skin. 
Figure 8. Impact of Krt16 expression on Nrf2 activation.              12 
Figure 9. A link between Krt16 and Nrf2 activation.             14 
Figure 10. Schematic of proposed regulation of Nrf2 pathway in the suprabasal          15 
    epidermis under normal physiological conditions and without K16. 
Figure 11. Treatment with SF prevents hyperkeratotic front paw calluses           16 
     in Krt16-/- mice. 
Figure 12. Topical treatment with SF results in increase of RACK1, PKCδ,           17 
     and PKCδ-P. 
Figure 13. Topical treatment of Krt16-/- paws with SF has sex-specific effects.          18 
Figure 14. Manipulation of ER signaling impacts responsiveness to SF treatment          19 








LIST OF TABLES 
 
Table 1. Characteristics of estrogen receptors.                8 






LIST OF ABBREVIATIONS 
 
ARE    Antioxidant responsive elements     
BSO    L-buthionine-sulfoximine 
C57BL/6   C57 black 6 
DPN    Diarylpropionitrile 
EBS    Epidermolysis bullosa simplex 
ER    Estrogen receptor 
G6PD    Glucose-6-phosphate dehydrogenase 
GCL    Glutamate cysteine ligase 
GCLC    Glutamate cysteine ligase catalytic subunit 
GCLM    Glutamate cysteine ligase modulatory subunit 
GS     Glutathione synthetase 
GSH    Glutathione 
GSR    Glutathione reductase 
GSSG    Glutathione disulfide  
GPX    Glutathione peroxidase 
HO-1    Heme oxygenase 1 
IPCC    International Pachyonychia Congenita Consortium 
K1 or KRT1   Keratin 1 
K5 or KRT5   Keratin 5 
K6a or KRT6a   Keratin 6a 
K6b or KRT6b  Keratin 6b 
K10 or KRT10  Keratin 10   




K16 or KRT16  Keratin 16 
K17 or KRT17  Keratin 17 
KEAP1   Kelch-like ECH-associating protein 1 
ME1/2   Malic enzymes 1 and 2 
NADPH   Nicotinamide adenine dinucleotide phosphate 
NQO1    NAD(P)H dehydrogenase quinone 1 
NRF2    Nuclear factor (erythroid-derived 2)-like 2 
P21    Cyclin-dependent kinase inhibitor 1 
PC    Pachyonychia congenita 
PKCδ    Protein kinase C delta 
PPK    Palmoplantar keratoderma 
RACK1   Receptor for activated C kinase 1 
ROS    Reactive oxygen species 
SF    Sulforaphane 
SMAD2   Mothers against decapentaplegic homolog 2 
TGFβ    Transforming growth factor beta 


















Keratins comprise the largest subgroup of intermediate filaments and function as the 
major structural proteins in epithelial cells (Coulombe and Omary, 2002). The keratin proteins 
can be grouped into two major types, type I or type II based on sequence homology (Figure 
1), which co-assemble in an obligatory and pairwise fashion to form 10 nm filaments 
(Coulombe and Omary, 2002; Fuchs and Hanukoglu, 1983).  
Historically, the Coulombe laboratory has referred to keratins 6a/b (K6a/b), keratin 16 (K16), 
and keratin 17 (K17) as the wound repair-associated keratins (Paladini et al., 1996).  The genes 
encoding for type II K6a/b and type I K16 and K17 are constitutively expressed in the 
epidermis of glabrous (hairless) skin and in all ectoderm-derived skin epithelial appendages 
(e.g., hair, nail, glands, tooth, thymus, etc.; Paladini et al., 1996). Expression of KRT6a, KRT6b, 





KRT16, and KRT17 are normally absent from interfollicular epidermis (and several related 
stratified epithelia) but are robustly induced following various types of insults, including UV 
exposure, wounding, and chronic inflammatory disease (McGowan and Coulombe, 1998). 
Upon wounding, K6a, K6b, K16, and K17 assume the spatial niche of the keratin 1 and keratin 
10 (K1 and K10) pairing, which is normally expressed in the differentiating suprabasal layer 






Figure 2. Specificity of keratin expression in human epidermis. (A) K5 and K14 are 
constitutively expressed in the basal layers, while K1 and K10 are constitutively expressed in 
the suprabasal layers of normal epidermis (adapted from Coulombe, 2011). (B) K6, K16, and 
K17 are robustly induced at the epidermal wound edge at the cost of keratins (ie. K10) that 





Pachyonychia congenita  
Pachyonychia congenita (PC) is a rare autosomal dominant genetic human skin disease 
that arises from mutations in keratin (KRT) 6a, 6b, 16, and 17 
(http://www.pachyonychia.org/pc_consortium.php). The prevalence of PC is currently 
unknown, but as of 2011, approximately 1000 patients have been registered with the 
International PC Consortium (IPCC) (http://www.pachyonychia.org/pc_consortium.php). 
PC is characterized by painful palmoplantar keratoderma (PPK) (Figure 3), hypertropic nail 
dystrophy, oral lesions, and cysts (Leachman et al., 2005). PC-associated PPK is acutely 
painful, debilitating, and severely compromises patient mobility 
(https://ghr.nlm.nih.gov/condition/pachyonychia-congenita). The two major subtypes of 
PC, PC Type 1 and PC Type 2 are caused by mutations in KRT6a/16 and KRT6b/17, 
respectively (Smith et al., 2005). Most mutations, which can be inherited or occur de novo, are 
missense or small in-frame deletions located in the “hotspot” regions at the ends of the central 
rod domain shared by all keratins (https://ghr.nlm.nih.gov/condition/pachyonychia-
congenita; Smith et al., 2005). Despite the molecular basis of PC having been uncovered over 
20 years ago, current treatment options are limited and consist of the chemical or mechanical 








Figure 3. Plantar skin of PC 
patient. Image depicts painful 
PPK calluses on the soles of the 
feet of a PC patient with L124R 
K16 mutation (reproduced from 




Keratin 16 null mice: faithful model of pachyonychia congenita-associated palmoplantar keratoderma 
Our laboratory has generated mice that are genetically null for Krt16 (C57BL/6 strain 
background). Krt16-/- mice are born alive and are initially macroscopically indistinguishable 
from wild-type (WT) and Krt16+/- littermates (Lessard and Coulombe, 2012). However, the 
null phenotype leads to increased postnatal mortality and failure to thrive: 34% of Krt16-/- mice 
die within 24 hours after birth, compared to 6% of WT and 11% of Krt16+/- mice (Lessard and 
Coulombe, 2012). This can be attributed in part to defective structural integrity of the oral 
mucosa in Krt16-/- mice (Lessard and Coulombe, 2012; Lessard et al.,2013). Beginning at four 
weeks of age, the surviving Krt16-/- mice begin to exhibit striking hyperkeratotic lesions that 
are histologically similar to PC-associated PPK (Lessard and Coulombe, 2012). There is an 
upregulation of genes related to inflammation and innate immunity in the Krt16-/- 
hyperkeratotic calluses that is also consist with PPK in individuals with PC (Lessard et al., 
2013). Given the morphological and molecular similarities with PC-associated PPK, the Krt16-
/- mouse provides the best animal model, so far, to better understand the pathogenesis of this 
disease.    
 
Redox balance of the skin 
 The skin serves a major role in defending the body against exogenous and endogenous 
sources of oxidative stress. Oxidative stress can arise as a consequence of defective production 
and/or detoxification of reactive oxygen species (ROS). In addition, harmful stimuli can evoke 
inflammatory responses, which if exaggerated, may aggravate pre-existing injury and cause 
addition tissue damage. 
Glutathione (GSH) is a thiol compound essential for maintaining cellular redox 




and glutathione disulfide (GSSG), respectively the reduced and oxidized forms of glutathione, 






GSH is a tripeptide (γ-L-glutamyl-L-cysteinylglycine) synthesized in a two-step process 
through glutamate cysteine ligase (GCL) and glutathione synthetase (GS). GCL is a 
heterodimer that catalyzes the initial rate-determining step of GSH synthesis; it is composed 
of an essential catalytic subunit (GCLC) and nonessential modulatory subunit (GCLM) 
(Dalton et al., 2000; Yang et al., 2002). GSH can ultimately prevent oxidative damage by 
consuming ROS through a redox reaction that converts GSH to GSSG via glutathione 
peroxidase (GPX). Conversely, glutathione reductase (GSR) recycles GSSG to GSH with the 
simultaneous oxidation of coenzyme nicotinamide adenine dinucleotide phosphate (NADPH) 
(Couto et al., 2013). NADPH levels are replenished by glucose-6-phosphate dehydrogenase 
(G6PD) and malic enzymes 1 and 2 (ME1/2). The activities of these enzymes in GSH 
metabolism determine the cellular levels of GSH and GSSG and the resulting GSH/GSSG 
ratio (Figure 4), which is used as an important measure of cellular toxicity (Pastore et al., 2001). 
Figure 4. Schematic 
representation of GSH 
metabolism. GSH synthesis 
and regeneration are closely 
linked in a cycle that permits 
the detoxification of ROS in 
order to reduce cellular 
oxidative stress (reproduced 





Nrf2 signaling pathway as a regulator of redox balance 
The transcription factor nuclear factor (erythroid-derived 2)-like 2 (NRF2) is a well-
known, master regulator of cellular redox homeostasis. Under basal conditions, NRF2 is 
sequestered in the cytoplasm by Kelch-like ECH-associating protein 1 (KEAP1) and targeted 
for proteasomal degradation (Itoh et al., 1999; Kobayashi et al., 2004). Oxidative and 
electrophilic stress results in the release, stabilization (i.e. phosphorylation), and nuclear 
translocation of NRF2.  In the nucleus, NRF2 binds to the antioxidant responsive elements 
(ARE) of its target genes, which includes genes encoding antioxidants (e.g. heme oxygenase 1 
(HO-1), NAD(P)H dehydrogenase quinone 1(NQO-1)) and GSH synthesis enzymes (Figure 





Sulforaphane (SF) is an isothiocyanate derived from broccoli sprout extract and a 
pharmacological inducer of NRF2 (Zhang et al., 1992). This phytochemical has been 
administered to humans in both oral and topical forms (Singh et al., 2014; Dinkova-Kostova 
et al., 2007). Our laboratory has previously used SF as a topical treatment in the setting of a 
Krt14-/- mouse model of epidermolysis bullosa simplex (EBS), a rare genetic skin disorder 
caused by mutations in basal keratins K5 or K14 and characterized by trauma-induced 
Figure 5. Schematic 
representation of KEAP1-
NRF2 signaling pathway. 
Under basal conditions, 
NRF2 is sequestered by 
KEAP1. Upon oxidative 
stress, NRF2 becomes 
phosphorylated and enters 






epithelial skin fragility and fluid-filled blisters (Coulombe et al., 2009). In this model, genetic 
ablation of K14 resulted in similar faulty skin integrity and blister formation, along with a 
postnatal mortality of approximately two-days (Kerns et al., 2007). Individuals with the 
equivalent of a KRT14 null mutation have all the hallmarks of EBS, similarly to Krt14-/- mice 
(Chan et al., 1994; Rugg et al., 1994; Lloyd et al., 1995). The topical use of SF was found to 
induce expression of K16 and K17 to compensate for the deficiency in K14; this resulted in 
greatly reduced cutaneous blistering along with improved postnatal survival (Kerns et al., 
2007). The rescue of the K14-/- phenotype displayed the powerful functional redundancy 
associated with keratins and offered insight into elucidating the pathophysiology and treatment 
options for PC. 
 
Estrogen signaling as a regulator of redox balance 
Along with NRF2 signaling, estrogen receptor (ER) signaling is also a major regulator 
of redox balance in humans. The two main ER isoforms, ERα and ERβ, are each relevant to 
skin biology (Table 1). In addition to its expression in classical estrogen-regulated tissues, ERα 
is stress-inducible in other tissues, including the skin, where it promotes cutaneous healing 
through the regulation of inflammation (Dahlman-Wright et al., 2006; Campbell et al., 2010). 
Conversely, ERβ is the major steroid receptor that is constitutively expressed in the skin and 



































Of particular relevance to our work are the differential effects of ERα and ERβ on NRF2 
signaling. ERα is able to directly inhibit NRF2-mediated transcription via a physical interaction 
at the promoter region of NRF2 target genes (Ansell et al., 2005). On the other hand, 
activation of ERβ by the selective agonist diarylpropionitrile (DPN) promotes Nrf2 nuclear 
translocation through an as yet defined mechanism in human cells (Zhang et al., 2013). 
Moreover, high levels of ERβ may overcome ERα-mediated repression of NRF2 (Lo and 
Matthews, 2013). Taken together, these findings point to the existence of a significant yet 
intricate relationship between ER- and NRF2-mediated responses.  
Here, we describe the utilization of the Krt16-/- murine model to examine the 
contribution of oxidative stress to the onset of PPK-like lesion in Krt16-/- mice and identify 
associated impairments in the NRF2 signaling pathway. We show that topical application of 
the NRF2 inducer SF prevents the formation of PPK-like lesions in male Krt16-/- mice.  
Additionally, we describe sex-specific differences in both lesion onset and SF responsiveness 
of Krt16-/- female skin that are related to fluctuations in ERα and ERβ expression and 
activation. 
Table 1. Characteristics of 
estrogen receptors. ERα and ERβ 
exhibit differential and often 
opposing effects in the skin (adapted 





 This thesis relates the outcome of experiments carried out by its author, alone or in 
collaboration with others, and is presented towards the partial fulfillment of the requirements 
for the Masters of Science (ScM) degree at the Johns Hopkins Bloomberg School of Public 
Health. The figures presented represent data directly generated by and include significant 
contributions from the author. The male-centric findings relevant to this thesis have been 
recently published in the Journal of Clinical Investigation (Kerns et al., 2016; a PDF copy of 
this article can be found in Appendix I), whereas the female-centric findings are being 





















Impaired glutathione synthesis in pre-lesional male Krt16-/- front paw tissue 
Pre-lesional paw tissue of one-month-old Krt16-/- males had a significant two-fold 
decrease in GSH levels relative to male WT control paw tissue, along with a net decrease in 
the GSH/GSSG ratio, from 37.9 ± 3.3 (WT) to 18.5 ± 4.7 (Krt16-/-) (Mean ± SEM; Appendix 
I, Figure 1B and C). In addition, molecular analyses revealed significant drops in GS and 
GCLC mRNA and protein levels, indicating that GSH synthesis enzymes were impaired, while 
GSR (regeneration pathway) was found to have no remarkable difference (Figure 6; Appendix 
I, Figure 1D and F). These findings suggest that increased oxidative stress, resulting mostly 
from a selective impairment of GSH synthesis, precedes the development of PPK-like lesions 









Lowering GSH levels causes PPK-like alterations in WT mouse skin 
 To assess the impact of lowered GSH levels on paw skin morphology, we treated one-
month-old WT males with intraperitoneal (i.p.) injections of 50 µmole L-buthionine-
sulfoximine (BSO), an inhibitor of GCL, twice weekly for four weeks. Relative to vehicle 
control, systemic BSO treatments resulted in a significant decrease of GSH (0.44 ± 0.14 fold) 
Figure 6.  Decrease in GSH synthesis in 
male Krt16-/- pre-lesional paw skin 
enzymes.  Representative western blot of 
GSH synthesis enzymes and K16 with actin 
as loading control.  GS, glutathione 
synthase; GCLC, glutamate cysteine ligase 
catalytic subunit; GCLM, glutamate 
cysteine ligase modulatory subunit 





and GSSG (0.50 ± 0.10 fold) in front paw tissue, while the GSH to GSSG ratio was not 
significantly altered (Mean ± SEM; Figure 7A and B). Despite no noticeable macroscopic 
difference between experimental and control paws (Figure 7C), the BSO treatment caused a 
significant 1.8 ± 0.1 fold increase in epidermal thickness (Mean ± SEM; Figure 7D and E) and 
the appearance of PPK-like downward epidermal projections, which is reflected in an 
increased dermo-epidermal interface to epidermal length ratio (Figure 7F). These findings 
suggest that increased oxidative burden generates modest but significant PPK-like alterations 

















Figure 7.  Systemic BSO treatment results in increased oxidative burden and 
epidermal changes in male murine paw skin. (A) Fold change of GSH and GSSG in paw 
tissue from 1 month old male WT mice treated with BSO relative to vehicle (PBS) treated 
controls. (B) GSH:GSSG ratio for the same mice. For A and B, data represents the mean ± 
SEM of 3 biological replicates. Student’s t test, *P value < 0.05. (C, D) Images and 
hematoxylin and eosin (H&E) staining of paw skin from 1 month old male WT mice treated 
with BSO or vehicle. Sc, stratum corneum, epi, epidermis, derm, dermis, and dotted line 
represents the dermo-epidermal junction.  Scale bar = 50 µm. (E) Fold change of epidermal 
thickness of paw skin of BSO treated mice relative to vehicle treated controls (PBS treated 
controls are set to one). (F) Dermo-epidermal junction/epidermal surface length ratio of paw 
skin of BSO and vehicle treated mice. For E and F, data calculated from 3 measurements for 
2 images from 3 mice per experimental group and represents the mean ± SEM. Student’s t 





The transcription factor Nrf2 is expressed, but is hypoactive in pre-lesional male Krt16-/- front paw skin 
Since the promoter region of KRT16 contains a functional ARE (Endo et al., 2008), 
we hypothesized that K16 may positively influence NRF2 activity and that this relationship 
may explain the impaired GSH synthesis observed in pre-lesional paws of Krt16-/- males 
(Figure 6). We found that Nrf2 and Keap1 protein levels are increased by at least two-fold in 
one-month-old male Krt16-/- paw tissue (Figure 8). The mRNA levels of Nrf2 and Keap1 are 
also increased 13.2 ± 2.4 fold and 7.7 ± 1.7 fold, respectively, in Krt16-/- male paw tissue (Mean 
± SEM; Appendix 1, Figure 2A). Since PKCδ-mediated phosphorylation of Nrf2 at serine 40 
permits the release of Nrf2 from Keap1 and promotes Nrf2 stabilization and nuclear 
translocation (Niture et al., 2009), we assessed protein levels of phosphorylated Nrf2 (Nrf2-P, 
Ser40) as well as total and phosphorylated PKCδ. Protein levels of Nrf2-P were substantially 
decreased in Krt16-/- paw skin relative to control. Likewise, total PKCδ and phosphorylated 
PKCδ (PKCδ-P, Thr505) protein levels were also down 2.7 ± 0.2 fold and 2.9 ± 0.3 fold, 
respectively (Mean ± SEM; Figure 8). Taken together, these findings suggest that although 









Figure 8. Impact of Krt16 
expression on Nrf2 activation.  
Representative western blot for Nrf2, 
Nrf2-P, Keap1, PKCδ, and PKCδ-P 
of three experiments with actin as 
loading control.  Arrow heads denote 
the three bands of Keap1 and the 
lower band that represents PKCδ.  
Nrf2-P, phospho-Nrf2; PKCδ-P, 
phospho-PKCδ (reproduced from 




Elucidating the link between Krt16 and Nrf2 activation 
To examine how K16 could impact PKCδ and subsequent Nrf2 activation, we first 
investigated the role of receptor for activated C kinase 1 (RACK1), a scaffolding protein that 
has been shown to stabilize the active conformations of PKCs, including PKCδ (Adams et al., 
2011). The RACK1 protein has been shown to physically interact with keratins 5 and 14, the 
main keratin pair of basal epidermal keratinocytes. This interaction results in sequestration of 
RACK1 and subsequent inhibition of PKCα activity upstream of desmosome assembly 
(Kroger et al., 2013). We hypothesized that, in contrast to K5 and K14, K16 would not interact 
with or sequester RACK1. In cultured 308 mouse skin keratinocytes transfected with GFP-
fused K16, little to no co-localization was identified between RACK1 and K16, whereas 
transfected GFP-fused K14 readily co-localized with RACK1 (Appendix 1, Figure 5C). To 
determine the physiological consequence of the absence of physical interaction between K16 
and RACK1, we also assessed RACK1 protein and mRNA levels. The RACK1 gene is a 
known NRF2 target (Kim et al., 2011), so we expected to find decreased RACK1 levels in 
light of the Nrf2 hypoactivity observed in Krt16-/- skin. We measured the expression of 
RACK1 protein through indirect immunofluorescence and Western blotting and found that 
RACK1 protein was markedly reduced in pre-lesional, one-month-old male Krt16-/- paw skin 
relative to WT control (Figure 9A and B). The 4.34 ± 0.03 fold reduction in 
immunofluorescence signal for RACK1 was significant (P < 0.01) in the epidermis of Krt16-/- 
skin, relative to WT control (Mean ± SEM; Appendix 1, Figure 5E). However, RACK1 mRNA 
levels remained comparable between Krt16-/- and WT paw skin, suggesting faulty RACK1 





NRF2 activation in skin keratinocytes also involves the TGF-β-dependent transcriptional 
activation of p21, a cyclin-dependent kinase inhibitor that competes with KEAP1 for NRF2 
binding (Oshimori et al., 2015; Chen et al., 2009). Cdkn1a, which encodes p21, is also an 
established target of the TGF-β–SMAD signaling pathway (Seoane et al., 2004; Koinuma et 
al., 2009). In total paw tissue, immunofluorescence signal and mRNA levels for p21 mRNA 
levels were both decreased by two fold in Krt16-/- relative to WT control (Figure 9A and C). 
The reduction in immunofluorescence signal for p21 was significant (P < 0.01) in Krt16-/- 
epidermis relative to WT control (Appendix 1, Figure 5E). Protein levels of p-SMAD2, a 
terminal effector of TGF-β signaling, were also substantially lower in Krt16-/- compared to WT 
control (Figure 9B).  
Figure 9. A link between Krt16 and Nrf2 activation. (A) Indirect immunofluorescence for 
RACK1 and p21 in paw skin. DAPI, nuclear staining, sc, stratum corneum, epi, epidermis, derm, 
dermis. Dotted line marks dermo-epidermal junction. Scale bar = 50 μm for original and 100 μm 
for inset. (B) Representative western blot for RACK1 and pSmad2 of 3 experiments with actin 
as loading control. (C) Fold change of mRNA for RACK1 and p21 in pre-lesional paw skin of 
Krt16-/- mice relative to WT.  Data represents the mean ± SEM of four biological replicates. 





Since RACK1 has been shown to promote and be a target of TGF-β signaling and 
overexpression of RACK1 has been correlated with increased p21 expression (Jia et al., 2013; 
Hermanto et al., 2002), we speculate that the remarkable drop in RACK1 levels in male Krt16-
/- paw skin may contribute to lower p21 levels and impairment of TGF-β signaling relative to 
WT control. Our findings indicate that K16, PKCδ activity, RACK1 protein synthesis and/or 
stability, TGF-β signaling, and p21 transcription are all intertwined in a network that can 
significantly modulate Nrf2 activity primarily in the suprabasal epidermis of Krt16-/- mice 
(Figure 10).  
 
Small molecule-based activation of Nrf2 rescues PPK in male Krt16-/- mice 
To further investigate the role of Nrf2 hypoactivity in PPK-like lesion formation in 
Krt16-/- mice, we topically treated the front paws of one-month-old male Krt16-/- mice with 
sulforaphane (SF), an Nrf2 inducer derived from broccoli sprouts twice weekly for four 
consecutive weeks (Zhang et al., 1992). Macroscopically, PPK-like lesions could not be readily 
identified in SF-treated Krt16-/- males (Appendix 1, Figure 6A). A blinded assessment of the 
PPK index (detailed in Materials and Methods) was conducted and revealed that the average 
affected surface area of SF-treated paws (0.08 ± 0.07) was dramatically lower than those of 
vehicle treatment (34.9 ± 3.2) (Mean ± SEM; n = 10 mice; Figure 11A).  
Figure 10. Schematic of proposed 
regulation of Nrf2 pathway in the 
suprabasal epidermis under normal 
physiological conditions and without 
K16. In the presence of K16 and under 
normal stress, we hypothesize that RACK1 
is able to permit the PKCδ-mediated 
phosphorylated of NRF2. However, 
without in PC, this mechanism becomes 














Histological analysis showed decreased epidermal thickness following SF treatment (Appendix 
1, Figure 6B). SF-treated Krt16-/- paws also had increased levels of Nrf2, Nrf2-P (Ser40), 
RACK1, PKCδ, and PKCδ-P (Figure 11B and 12; Appendix 1, Figure 6C). Interestingly, GSH 
levels remained similar regardless of SF or vehicle treatment, but GSSG levels decreased 2.56 
± 0.05 fold after SF treatment (Mean ± SEM; Appendix 1, Figure 6E), leading to an increase 
in GSH to GSSG ratio (19.9 ± 0.9 in vehicle-treated versus 47.1 ± 7.8 in SF-treated Krt16-/- 
paw tissue), which indicates a decrease in oxidative stress (Mean ± SEM; Appendix 1, Figure 
6F). Surprisingly, SF treatment resulted in lower mRNA levels for both GS and GCLC, but 
elevated mRNA expression of GSR relative to vehicle oil treatment (6.6 ± 2.4 fold increase; 
Mean ± SEM) (Appendix 1, Figure 6G and H). This indicates that GSH synthesis remains 
impaired despite Nrf2 induction, while GSH regeneration is improved. Taken together, these 
results suggest that topical treatment with SF successfully prevented PPK-like lesion 
formation, activated Nrf2, and decreased oxidative burden in one-month-old male Krt16-/- paw 
tissue.  
 
Figure 11.  Treatment with SF 
prevents hyperkeratotic front 
paw calluses in Krt16-/- mice. (A) 
Quantitation of PPK index.  (B) 
Representative western blot of 
Nrf2 and Nrf2-P with actin as 
loading control. **P-value < 0.01 







Topical treatment of Krt16-/- paws with SF exhibits sex-specific effects 
 We postulated that the twice-weekly topical treatment regimen with SF, which 
successfully prevented PPK-like lesions in male Krt16-/- mice, would be equally effective in 
female Krt16-/- mice. Utilizing a new group of male and female Krt16-/- mice, we repeated the 
topical SF treatment regimen described above. With this second cohort of mice, we replicated 
our success with SF treatment in Krt16-/- males (Figure 13A). The PPK indices for vehicle-
treated and SF-treated Krt16-/- male paws were 39.1 ± 2.4 and 0, respectively (Mean ± SEM; n 
= 8 mice per sex for each treatment group; Note: PPK = 0 indicates no lesional area noted; 
Figure 13B). Surprisingly, SF treatment did not appear to impact lesion development in female 
Krt16-/- mice (Figure 13A). There was no significant difference between the PPK indices for 
vehicle-treated and SF-treated female Krt16-/- paws (11.9 ± 2.6 versus 10.1 ± 0.6, respectively; 
Figure 12. Topical treatment with SF 
results in increase of RACK1, PKCδ, 
and PKCδ-P. Representative images of 
indirect immunofluorescence staining for 
RACK1, PKCδ, PKCδ-P in Krt16-/- paw 
skin treated with SF or jojoba oil (vehicle). 
PKCδ-P, phospho-PKCδ; DAPI, nuclear 
staining; sc, stratum corneum; epi, 
epidermis; derm, dermis. Scale bar = 50 
μm. Dotted line marks the dermo-
epidermal junction (reproduced from 




Mean ± SEM; n = 8 mice per sex for each treatment group). Unlike the Krt16-/- males, the 
Krt16-/- females showed no reduction of epidermal thickening of paw skin following SF 













Manipulation of ER signaling impacts responsiveness to SF treatment in female Krt16-/- mice 
Given the opposing effects of ERα and ERβ on each other and on Nrf2 signaling, 
and their fluctuating levels in female Krt16-/- paw tissue (Kerns et al., unpublished data), we 
postulated that a dominance of ERα over ERβ, may explain the failure of SF treatments to 
activate NRF2 in female Krt16-/- paw tissue. We developed a combination treatment consisting 
of i.p. injections of 5µg/kg mouse DPN in addition to topical SF for treating one-month-old 
Krt16-/- females. After treating twice weekly for four weeks, front paws were harvested for 
morphological analysis and indirect immunofluorescence. Krt16-/- females that received both 
DPN and SF had a remarkable absence of PPK-like lesions on front paws relative to SF-
Figure 13. Topical treatment of Krt16-/- paws with SF has sex-specific effects. 
(A) Representative images of male and female Krt16-/- paws following SF or vehicle 
(OIL) treatment. Arrow heads point to affected areas.  PPK index following SF or 
vehicle (OIL) treatment per sex. Mean ± SEM. n = 8 mice per sex. (C) H&E staining 
of male and female Krt16-/- paws following SF or vehicle (OIL) treatment. Scale bar 




treated controls (Figure 14A). Indirect immunofluorescence staining for NRF2 and p-NRF2 
indicated a mild increase in total NRF2 protein, but a striking activation of NRF2 in the basal 
cell layer of the epidermis as well as an increase of NQO-1 in dual treated Krt16-/- females 
(Figure 14B). These findings indicate that SF responsiveness in Krt16-/- females may be 
influenced by ER signaling. Indirect immunofluorescence staining for these targets in an 



















Figure 14. Manipulation of ER 
signaling impacts responsiveness to SF 
treatment in Krt16-/- female mice. (A) 
Representative images of Krt16-/- female 
paws following DPN and SF or SF-only 
treatment. (B) Representative images of 
indirect immunofluorescence staining for 
NRF2, NRF2-P, and NQO-1 in Krt16-/- 
female paw skin treated with DPN and SF 
or SF-only treatment.  NRF2-P, phospho-
NRF2; DAPI, nuclear staining; epi, 
epidermis; derm, dermis. Scale bar = 50 μm.  
Dotted line marks the dermo-epidermal 






In this thesis, we determined that oxidative stress associated with decreased GSH 
synthesis and misregulated NRF2 signaling precedes the formation of PPK-like lesions in male 
Krt16-/- mice. We linked the NRF2 hypoactivity observed in Krt16-/- paw skin to the 
hypoactivity of its upstream modifiers, RACK1 and PKCδ. Moreover, we find that topical 
treatment with an NRF2 inducer, SF, prevents these PPK-like lesions and restores redox 
balance. Finally, we uncover a sex bias in how Nrf2 is regulated in skin keratinocytes of male 
vs. female skin keratinocytes.  
Taken together, these findings pinpoint a potential role for K16 in the regulation of 
the oxidative stress response of the skin, possibly through the modulation of NRF2 signaling. 
Upon wounding or stress to the skin epithelium, both K16 and NRF2 are upregulated in 
epidermal keratinocytes (Paladini et al., 1996; Braun et al., 2002). Our laboratory previously 
found that Krt16 expression is typically confined to the suprabasal epidermis (Paladini et al., 
1996). In response to ultraviolet (UV) B irradiation, Nrf2 is known to stimulate GSH synthesis 
and distribution in suprabasal keratinocytes and subsequently protect neighboring basal cells 
via a GSH-mediated gradient (Schafer et al., 2010). Our study demonstrates that the loss of 
Krt16 specifically affects Nrf2-regulated GSH production. We find that K16 does not appear 
to sequester RACK1, in contrast to K5 and K14, and that the lack of K16 also results in lower 
RACK1 protein levels and phosphorylated PKCδ in hairless skin. In addition, TGF-β 
signaling through SMAD2 and TGF-β activation of p21, an NRF2 stabilizer, are impaired 
without the presence of K16. K16 expression is known to be stimulated by TGF-β (Choi and 
Fuchs, 1990), thus our findings suggest that K16 may influence redox balance in glabrous skin 




TGF-β. The effect of K16 on TGF-β signaling may lend support to a previously deduced 
epidermal gradient of NRF2 that results from UVB irradiation-induced stress (Schafer et al., 
2010). Taken together, we suggest that K16 may be a major player in maintaining redox 
balance in the epidermis of glabrous skin and that K16 may control NRF2 activation in skin 
keratinocytes experiencing stress.   
Another key finding from our study has been the ineffectiveness of SF in female Krt16-
/- mice, which may be related to ER signaling. The phenotypic rescue in male Krt16-/- mice 
establishes the importance of the NRF2 pathway in the pathophysiology of PPK-like lesions. 
However, SF treatment alone was not sufficient to prevent lesion formation in female Krt16-/- 
mice. In a revised treatment regimen for Krt16-/- females, we were able to inhibit PPK-like 
lesion formation by supplementing SF treatments with ERβ agonist, DPN. Given that ERβ 
has been shown to promote Nrf2 nuclear translocation (Zhang et al., 2013), these results 
suggest that estrogen receptor signaling could be a notable player in lesion formation and SF 
responsiveness. 
Whether oxidative stress stemming from alterations in GSH production and/or 
metabolism plays a similar role in the pathophysiology of PPK in PC patients remains to be 
investigated. Despite uncovering the molecular basis of PC as a keratin gene disorder over 20 
years ago, current treatment options (e.g. mechanical or surgical removal of calluses, allele-
specific silencing) are limited and ineffective (Smith et al., 2005). The pharmacological 
restoration of redox balance and NRF2 signaling represents an additional, and potentially 
more effective, avenue through which to achieve a substantial clinical improvement of PPK. 
Our enriched understanding of the pathophysiology of PC-associated PPK sheds insight into 
mechanisms behind conditions of impaired wound healing or oxidative stress response and 




MATERIALS AND METHODS 
Animals, antibodies, and preparation of SF and DPN treatments 
A Krt16-/- mouse line (C57BL/6 strain background) were generated by our laboratory 
and has since been maintained under specific pathogen-free conditions (Lessard et al., JID, 
2012). Commercial antibodies used include β-actin (sc-47778, Santa Cruz), GCLC (sc-28965, 
Santa Cruz), GCLM (ab124827, Abcam), GS (ab91591, Abcam), Keap1 (#4617S, Cell 
Signaling), Nrf2 (sc-13032, Santa Cruz), p-Nrf2 (PAR2020, NeoBiolab), PKCδ (sc-213, Santa 
Cruz), p-PKCδ (#9374, Cell Signaling), RACK1 (sc-17754, Santa Cruz), and p-Smad2 (#3101, 
Cell Signaling). Generation of the anti-K16 antibody has been previously described (Bernot et 
al., JID, 2002). Alexa Fluor-conjugated and HRP-conjugated secondary antibodies (Life 
Technologies) were also used for indirect immunofluorescence and Western blotting, 
respectively. Sulforaphane (SF) was obtained from LKT Laboratories and jojoba oil (vehicle) 
was obtained from MP Biomedicals LLC. Stock solutions of SF were maintained at 0.1M in 
DMSO and diluted to the desired final concentration in jojoba oil for topical application on 
the day of the treatment (Kerns et al., Mol Cell Biol, 2010; Dinkova-Kostova et al., Cancer 
Epidemiol Biomarkers Prev, 2007). DPN was obtained from Sigma-Alrich and 1X PBS 
(vehicle) was obtained from Life Technologies. Stock solutions of DPN were maintained at 
1µM in DMSO and diluted to the desired final concentration in PBS for i.p. injection on the 
day of the treatment (Campbell et al., JEM, 2010).  
 
Mouse studies 
All studies involving mice were reviewed and approved by the Johns Hopkins 




Four- and six-week-old Krt16-/- or WT male mice were topically treated with either 
100µl of 1µmole SF or vehicle control on their front paws twice weekly for four weeks, after 
which the front paws were harvested for biochemical and morphological analysis. The ventral 
surface of each treated paw was photographed and the extent of PPK-like lesions was blindly 
and independently assessed by five individuals. 
Four-week-old WT mice were given i.p. injections of 50µmole BSO (Sigma-Aldrich), 
an inhibitor of GSH synthesis, in PBS or PBS alone twice weekly for four weeks (Kerns et al., 
Mol Cell Biol, 2010). Upon completion of treatment, the front paws were harvested for 
molecular and histological analysis. 
Four-week-old Krt16-/- or WT female mice were topically treated in the same manner 
as the male counterparts and received i.p. injections of 5µg/kg mouse DPN, an ERβ agonist, 
in PBS or PBS alone twice weekly for four weeks. Post-treatment harvest and analysis were 
performed identically to the male counterparts. 
 
Biochemical and morphological analysis 
The PPK index was generated from a blinded assessment of 10-15 front paw images 
de-identified for age, sex, genotype, and type of treatment received. Each paw was evaluated 
for percentage of area affected by hyperpigmentation at 10 different pressure sites. Each set 
of PPK indices was assessed by 3-5 individuals, all of whom had no involvement in the 
compilation of images. RNA was extracted from front paws using TriPure Isolation Reagent 
(Sigma-Aldrich) and purified with DNAse treatment using NucleoSpin RNA Clean-up 
(Macherey-Nagel). The amount of 1µg of total RNA from each sample was reverse transcribed 
using an iScript cDNA Synthesis Kit (Bio-Rad) and quantitative RT-PCR was performed as 




used and are listed in Table 2. Protein was also extracted from front paws using TriPure 
Isolation Reagent (Sigma-Aldrich) and concentration was measured using a Bradford Assay 
Kit (Bio-Rad). For Western blotting, protein (15-20µg) was loaded onto 10% SDS-PAGE gels 
and blotted onto nitrocellulose membranes using standard methods. Blocking conditions, as 
wells as primary and secondary antibody dilution buffers, used 5% BSA (P212121 store). Actin 
was used as a loading control in all immunoblots. Bound primary antibodies were detected 
with enhanced chemiluminescence (Therm Scientific) and imaged using the FluorChem Q 
system. GSH and GSSG levels in paw tissue were assessed using the Glutathione Fluorometric 
Assay Kit (BioVision). For histological analysis, paw tissue was embedded in OCT (Sakura 
Finetek), frozen in dry ice, and stored at -20oC upon sectioning. Tissue sections were 
consistently cut at 8µm in a transverse orientation relative to paw morphology. Histopathology 
was obtained through H&E staining and indirect immunofluorescence was performed with 
primary and Alexa Fluor-conjugated secondary antibodies (Hobbs et al., Nat Genet, 2015).  
 
Statistics 
Unpaired 2-tailed Student’s t test and ANOVA were performed for statistical analysis. 
Significant differences between two groups are noted by individual or paired asterisks in the 
figures included in this thesis. Blinded quantitation of indirect immunofluorescence and 
Western blotting was performed using ImageJ (NIH) and relevant data is presorted as mean 





Table 2. List of oligonucleotide primer sequences. 
 
Target Forward Reverse 
Actin 5’-TGGAATCCTGTGGCATCCATGAAAC-3’ 3’-TAAAACGCAGCTCAGTAACAGTCCG-5’ 
G6PD 5’-ACCATCTGGTGGCTGTTCC-3’ 3’-CATTCATGTGGCTGTTGAAGG-5’ 
Gclc 5’-ACATCTACCACGCAGTCAAGGACC-3’ 3’-CTCAAGAACATCGCCTCCATTCAG-5’ 
Gclm 5’-GCCCGCTCGCCATCTCTC-3’ 3’-GTTGAGCAGGTTCCCGGTCT-5’ 
Gs 5’-CAAAGCAGGCCATAGACAGGG-3’ 3’-AAAAGCGTGAATGGGGCATAC-5’ 
Hmox1 5’-CTGTGTAACCTCTGCTGTTCC-3’ 3’-CCACACTACCTGAGTCTACC-5’ 
Keap1 5’-CATCCACCCTAAGGTCATGGA-3’ 3’-GACAGGTTGAAGAACTCCTCC-5’ 
Me1 5’-GATGATAAGGTCTTCCTCACC-3’ 3’-TTACTGGTTGACTTTGGTCTGT-5’ 
Me2 5’-TTCTTAGAAGCTGCAAAGGC-3’ 3’-TCAGTGGGGAAGCTTCTCTT-5’ 
Nqo1 5’-AGGATGGGAGGTACTCGAATC-3’ 3’-AGGCGTCCTTCCTTATATGCTA-5’ 
Nrf2 5’-TCTCCTCGCTGGAAAAAGAA-3’ 3’-AATGTGCTGGCTGTGCTTTA-5’ 
p21 5’-CGAGAACGGTGGAACTTTGAC-3’ 3’-CAGGGCTCAGGTAGACCTTG-5’ 
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Kerns, M. L., Hakim, J. M., Lu, R. G., Guo, Y., Berroth, A., Kaspar, R. L., 
and Coulombe, P.A. (2016). Oxidative stress and dysfunctional NRF2 
underlie pachyonychia congenita phenotypes. The Journal of Clinical 
Investigation, 126(6), 2356-2366. 
 
Barberio, M.D., Lu, R., and Hubal, M.J. (2015). Optimal Physical Activity & 
Exercise Following Bariatric Surgery. In Mandy Chambers (Ed.), Bariatric 
Surgery: Prevalence, Complications and Impact on Quality of Life. Hauppauge, NY: 




Fujimoto, K., Matsuura, K., Hu-Wang, E., Lu, R., and Shi, Y.B. (2012). 
Thyroid Hormone Activates Protein Arginine Methyltransferase 1 Expression by Directly 
Inducing c-Myc Transcription during Xenopus Intestinal Stem Cell Development. J Biol 
Chem, 287(13), 10039-10050.   
 
Sun, G., Hasebe, T., Fujimoto, K., Lu, R., Fu, L., Matsuda, H., Kajita, M., 
Ishizuya-Oka, A., and Shi, Y.B. (2010). Spatio-Temporal Expression Profile of Stem 
Cell-Associated Gene LGR5 in the Intestine during Thyroid Hormone-Dependent 
Metamorphosis in Xenopus laevis. PLoS One, 5(10), e13605.  
 
PRESENTATIONS 
Lu, R. Vive la difference: Designing a sex-specific approach for the 
treatment of pachyonychia congenita (PC). Presented at the Johns Hopkins 
Bloomberg School of Public Health Department of Biochemistry and 
Molecular Biology Research Retreat, Baltimore, MD (2016). 
 
Lu, R., Hakim, J.M., Kerns, M. L., Castellanos, C., Coulombe, P.A. Sex: A  
neglected variable in oxidative stress-associated skin biology." Presented at 
the Johns Hopkins Bloomberg School of Medicine Department of 
Dermatology Research Day, Baltimore, MD (2016). 
 
Lu, R., Kerns, M. L., Hakim, J.M., Guo, Y., and Coulombe, P.A. Defining 
the role of keratin 16 in wound-associated oxidative stress." Presented at the 
Johns Hopkins Bloomberg School of Public Health Delta Omega Scientific 
Poster Competition, Baltimore, MD (2016).  
 
Lu, R., Sevilla, S., Nadler, E.P., and Hubal, M.J. FTO genotype is associated 
with ALT levels in obese adults. Presented at the George Washington 
University Research Days, Washington, DC (2014). 
